サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：HbA1cラボ検査の世界市場：成長、将来展望、競合分析 (2025年～2033年)
市場調査レポート
商品コード
1645222

HbA1cラボ検査の世界市場：成長、将来展望、競合分析 (2025年～2033年)

HbA1c Laboratory Testing Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HbA1cラボ検査の世界市場：成長、将来展望、競合分析 (2025年～2033年)
出版日: 2024年12月10日
発行: Acute Market Reports
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療診断の領域において、HbA1cラボ検査は、特に糖尿病管理とモニタリングにおいて極めて重要な役割を担っています。HbA1c検査は、3ヶ月間の平均血糖値を提供し、臨床医に患者の血糖コントロールに関する貴重な洞察を提供します。HbA1cラボ検査市場は2025年から2033年にかけてCAGR 5.5%で成長すると推定されます。これは、世界の健康動向から急速な技術進化に至るまで、技術の進歩に影響された無数の要因によるものです。

促進要因：世界の糖尿病有病率の上昇

糖尿病が世界的に公衆衛生の重要な関心事となりつつある中、HbA1cラボ検査を含む効果的なモニタリングツールに対する需要が著しく急増しています。例えば、世界保健機関 (WHO) は過去10年間、世界的に糖尿病患者が着実に増加していることを報告しており、この健康上の苦境の大きさと緊急性を示しています。これに伴い、HbA1c検査は医療現場において不可欠なものとなっています。定期的なHbA1c検査は、タイムリーな介入、投薬レジメンの調整を可能にし、神経障害、腎症、網膜症などの糖尿病関連合併症の予防を支援することで、患者の転帰改善に結びついています。

機会：診断におけるAIと機械学習の統合

人工知能 (AI) と機械学習 (ML) の領域における技術の進歩は、HbA1cラボ検査市場に新たな地平を開いています。HbA1cの結果やその他の患者データに基づいて糖尿病の進行や関連合併症を予測するためにAIアルゴリズムを活用することへの関心が高まっています。例えば、いくつかの医療・テクノロジー新興企業や既存の診断ラボは、HbA1c検査結果からより実用的な分析を提供するために、AI主導の予測分析を統合する方法を模索しています。これにより、検査の臨床的有用性が高まるだけでなく、予防医療のレイヤーが追加され、臨床医による積極的な患者管理が支援されます。

抑制要因：低所得地域における高い検査費用と限られたアクセス性

HbA1c検査の重要性は否定できないにもかかわらず、多くの人々にとってコストが大きな障壁となっています。いくつかの地域、特に低・中所得国では、定期的なHbA1c検査に伴う費用は法外です。さらに、保険によってはHbA1c検査が適用されないため、患者の自己負担が増えます。さらに、高度な検査室や熟練した技術者を含む必要なインフラが普遍的に利用できるわけではないため、検査へのアクセスがさらに制限される可能性があります。このような医療インフラの格差は、国際糖尿病連合による報告書でも明らかであり、先進国と発展途上国の糖尿病医療アクセスにおける著しいコントラストを浮き彫りにしています。

課題：ばらつきと標準化への懸念

HbA1c検査における喫緊の課題は、検査結果のばらつきです。検査施設によって検査手法が異なるため、結果にわずかなばらつきが生じる可能性があります。このことは、特に患者が医療機関を変えたり、臨床医が複数の検査機関の結果を信頼したりする場合に課題となります。米国糖尿病学会は以前、HbA1c検査の標準化に関する懸念を強調し、統一性と信頼性を確保するために世界的に一貫した検査プロトコルの必要性を強調しています。

技術別の分析

2024年、HbA1cラボ検査市場を独占していたテクノロジーは、複数のカテゴリーに分別される可能性があります。イオン交換高速液体クロマトグラフィー (HPLC) は、その精度、再現性、堅牢性により、最も高い収益を上げる技術として浮上しました。HbA1c値のわずかな変動も正確に検出できることから、世界中の臨床医に支持されました。しかし、免疫測定法が最も高いCAGRを示したのは、主にその迅速な検査能力と、南アジアのような人口の多い地域にとって重要な大量スクリーニングのための拡張性が理由です。ホウ素酸アフィニティークロマトグラフィーと直接酵素測定法は、あまり普及していないもの、特定の臨床シナリオにおいてニッチなソリューションを提供しました。その他の技術も市場を補完し、特殊なニーズに対応したり、特定の診断嗜好を持つ地域にサービスを提供しています。

エンドユーザー別の分析

2024年の市場収益に大きく貢献したのは診断ラボでした。広大なネットワーク、可用性、HbA1c検査の専門性により、多くの医療プロバイダーにとって主要な選択肢となっています。一方、病院を拠点とする検査施設は、かなりの収益をあげているもの、CAGRは最も高いです。この動向は、糖尿病患者の増加や、迅速な介入を保証する院内検査施設の利便性に起因していると考えられます。調査研究所のような他の事業体も、特に臨床研究や調査の文脈でその役割を果たしています。

地域別分析

地域別では、2024年には北米が糖尿病有病率の高さ、高度な医療インフラ、患者の意識を背景に、売上高で市場を独占しました。しかし、アジア太平洋地域は2025年から2033年にかけて最も高いCAGRを示すと予想されています。インドや中国のような国々で糖尿病人口が急増していることに加え、医療支出の増加や診断施設の台頭といった要因が、この成長に拍車をかけると思われます。成熟した医療システムを有する欧州は引き続き大きな貢献を果たすと思われ、ラテンアメリカとアフリカは、医療へのアクセスと手頃な価格に関する課題はあるもの、潜在的な成長機会を提供すると思われます。

競合動向

市場競争情勢は常にダイナミックです。2024年には、Abbott Laboratories、Bio-Rad Laboratories、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Siemens Healthcare GmbH、Thermo Fisher Scientific, Inc.、Ortho Clinical Diagnostics、ARKRAY, Inc.、EKF Diagnostics Holdings plc、Meril Life Science Pvt. Ltd.などの主要企業が、高度なHPLCおよび免疫測定ソリューションを武器に優位を占める。各社の戦略は調査、地理的拡大、診断・研究機関との提携に重点を置いています。2025年から2033年までの予測では、これらの大手企業はAIの統合と自動化をより深く掘り下げ、新興市場での足跡を広げ、迅速でスケーラブルかつ正確なHbA1c検査ソリューションのニーズに対応すると予想されます。

目次

第1章 序文

  • 分析内容
    • 分析の目的
    • 対象者
    • 主な提供内容
  • 市場セグメンテーション
  • 分析手法
    • フェーズⅠ：二次調査
    • フェーズⅡ：一次調査
    • フェーズⅢ：有識者レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 HbA1cラボ検査市場：競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーが採用した戦略
  • 主要な産業戦略

第4章 HbA1cラボ検査市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のHbA1cラボ検査市場 (金額ベース、2023～2033年)
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
    • サプライヤーパワー
    • バイヤーパワー
    • 代替品の脅威
    • 新規参入業者の脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治的情勢
    • 経済的情勢
    • 技術的情勢
    • 法的情勢
    • 社会的情勢

第5章 HbA1cラボ検査市場：技術別 (2023～2033年)

  • 市場概要
  • 成長・収益分析：2024年 vs 2033年
  • 市場セグメンテーション
    • イオン交換高速液体クロマトグラフィー (HPLC)
    • 免疫測定
    • ホウ酸アフィニティークロマトグラフィー
    • 直接酵素アッセイ
    • その他

第6章 HbA1cラボ検査市場：エンドユーザー別 (2023～2033年)

  • 市場概要
  • 成長・収益分析：2024年 vs 2033年
  • 市場セグメンテーション
    • 診断検査室
    • 病院内検査室
    • その他 (研究機関等)

第7章 北米のHbA1cラボ検査市場 (2023～2033年)

  • 市場概要
  • HbA1cラボ検査市場：技術別 (2023～2033年)
  • HbA1cラボ検査市場：エンドユーザー別 (2023～2033年)
  • HbA1cラボ検査市場：地域別 (2023～2033年)
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第8章 北米のHbA1cラボ検査市場 (2023～2033年)

  • 市場概要
  • HbA1cラボ検査市場：技術別 (2023～2033年)
  • HbA1cラボ検査市場：エンドユーザー別 (2023～2033年)
  • HbA1cラボ検査市場：地域別 (2023～2033年)
    • 英国・EU諸国
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第9章 アジア太平洋のHbA1cラボ検査市場 (2023～2033年)

  • 市場概要
  • HbA1cラボ検査市場：技術別 (2023～2033年)
  • HbA1cラボ検査市場：エンドユーザー別 (2023～2033年)
  • HbA1cラボ検査市場：地域別 (2023～2033年)
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第10章 ラテンアメリカのHbA1cラボ検査市場 (2023～2033年)

  • 市場概要
  • HbA1cラボ検査市場：技術別 (2023～2033年)
  • HbA1cラボ検査市場：エンドユーザー別 (2023～2033年)
  • HbA1cラボ検査市場：地域別 (2023～2033年)
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第11章 中東・アフリカのHbA1cラボ検査市場 (2023～2033年)

  • 市場概要
  • HbA1cラボ検査市場：技術別 (2023～2033年)
  • HbA1cラボ検査市場：エンドユーザー別 (2023～2033年)
  • HbA1cラボ検査市場：地域別 (2023～2033年)
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第12章 企業プロファイル

  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Ortho Clinical Diagnostics
  • ARKRAY Inc.
  • EKF Diagnostics Holdings plc
  • Meril Life Science Pvt. Ltd.
  • その他
図表

List of Tables

  • TABLE 1 Global HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 2 Global HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 3 North America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 4 North America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 5 U.S. HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 6 U.S. HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 7 Canada HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 8 Canada HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 9 Rest of North America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 10 Rest of North America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 11 UK and European Union HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 12 UK and European Union HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 13 UK HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 14 UK HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 15 Germany HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 16 Germany HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 17 Spain HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 18 Spain HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 19 Italy HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 20 Italy HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 21 France HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 22 France HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 23 Rest of Europe HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 24 Rest of Europe HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 25 Asia HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 26 Asia HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 27 China HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 28 China HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 29 Japan HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 30 Japan HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 31 India HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 32 India HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 33 Australia HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 34 Australia HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 35 South Korea HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 36 South Korea HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 37 Latin America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 38 Latin America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 39 Brazil HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 40 Brazil HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 41 Mexico HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 42 Mexico HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 43 Rest of Latin America HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 44 Rest of Latin America HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 45 Middle East and Africa HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 46 Middle East and Africa HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 47 GCC HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 48 GCC HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 49 Africa HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 50 Africa HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)
  • TABLE 51 Rest of Middle East and Africa HbA1c Laboratory Testing Market By Technology, 2023-2033, USD (Million)
  • TABLE 52 Rest of Middle East and Africa HbA1c Laboratory Testing Market By End-user, 2023-2033, USD (Million)

List of Figures

  • FIG. 1 Global HbA1c Laboratory Testing Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global HbA1c Laboratory Testing Market: Quality Assurance
  • FIG. 5 Global HbA1c Laboratory Testing Market, By Technology, 2024
  • FIG. 6 Global HbA1c Laboratory Testing Market, By End-user, 2024
  • FIG. 7 Global HbA1c Laboratory Testing Market, By Geography, 2024
  • FIG. 8 Market Geographical Opportunity Matrix - Global HbA1c Laboratory Testing Market, 2024
  • FIG. 9Market Positioning of Key HbA1c Laboratory Testing Market Players, 2024
  • FIG. 10 Global HbA1c Laboratory Testing Market, By Technology, 2024 Vs 2033, %
  • FIG. 11 Global HbA1c Laboratory Testing Market, By End-user, 2024 Vs 2033, %
目次
Product Code: 114-12-24

In the realm of healthcare diagnostics, HbA1c laboratory testing holds a pivotal role, particularly in the context of diabetes management and monitoring. HbA1c tests provide an average blood glucose level over a period of three months, offering clinicians valuable insight into a patient's glycemic control. HbA1c laboratory testing market is estimated to grow at a CAGR of 5.5% from 2025 to 2033, driven by influenced by a myriad of factors ranging from global health trends to rapid technological evolution, influenced by technological advancements.

Driver - The Rising Global Prevalence of Diabetes

With diabetes becoming a significant public health concern worldwide, the demand for effective monitoring tools, including HbA1c laboratory tests, has witnessed a remarkable surge. Evidences highlight the alarming increase in diabetes incidence; for instance, the World Health Organization (WHO) had reported in the past decade about a steady rise in diabetes cases globally, signifying the sheer magnitude and urgency of this health predicament. In line with this, HbA1c tests have become indispensable in medical practice. Regular HbA1c testing allows for timely intervention, adjustment of medication regimens, and has been linked to better patient outcomes by aiding in the prevention of diabetes-related complications such as neuropathy, nephropathy, and retinopathy.

Opportunity - Integration of AI and Machine Learning in Diagnostics

Technological advancements in the realm of artificial intelligence (AI) and machine learning (ML) are opening new horizons for the HbA1c laboratory testing market. There's growing interest in utilizing AI algorithms to predict diabetes progression and related complications based on HbA1c results and other patient data. For example, several healthcare technology startups and established diagnostic labs are exploring ways to integrate AI-driven predictive analytics to offer more actionable insights from HbA1c test results. This not only augments the clinical utility of the test but also adds a layer of preventive care, assisting clinicians in proactive patient management.

Restraint - High Cost of Testing and Limited Accessibility in Low-Income Regions

Despite the undeniable importance of HbA1c tests, the cost remains a considerable barrier for many. In several regions, especially in low-to-middle income countries, the expense associated with regular HbA1c testing can be prohibitive. Moreover, some insurance policies do not cover HbA1c testing, adding to the out-of-pocket costs for patients. Additionally, the requisite infrastructure, including advanced laboratories and skilled technicians, might not be universally available, further restricting test accessibility. Such disparities in healthcare infrastructure were evident in a report by the International Diabetes Federation, which highlighted stark contrasts in diabetes care access between developed and developing nations.

Challenge - Variability and Standardization Concerns

One of the more pressing challenges in the HbA1c testing arena is the potential variability in test results. Different laboratories might use diverse testing methodologies, potentially leading to slight variances in outcomes. This poses a challenge, especially when patients switch healthcare providers or when clinicians rely on results from multiple labs. The American Diabetes Association has previously highlighted concerns regarding the standardization of HbA1c tests and has emphasized the need for globally consistent testing protocols to ensure uniformity and reliability.

Technology Insights

In 2024, the technologies that dominated the HbA1c laboratory testing market could be segregated into multiple categories. Ion Exchange High-Performance Liquid Chromatography (HPLC) emerged as the highest revenue-generating technology, attributed to its precision, repeatability, and robustness. Clinicians globally favored it for its accuracy in detecting even minor variances in HbA1c levels. However, Immunoassay showed the highest CAGR, mainly because of its rapid testing capabilities and its scalability for mass screenings, crucial for populous regions like South Asia. Boronate Affinity Chromatography and Direct Enzymatic Assay, although less prevalent, provided niche solutions in specific clinical scenarios. Other technologies complemented the market, catering to specialized needs or serving regions with specific diagnostic preferences.

End-User Insights

Diagnostic Laboratories in 2024 were the major contributors to the market's revenue. Their vast network, availability, and specialization in HbA1c testing made them the primary choice for many healthcare providers. On the other hand, Hospital-based Laboratories, though generating substantial revenue, were marked with the highest CAGR. This trend could be attributed to the rising in-patient diabetic population and the convenience of in-hospital testing facilities, ensuring prompt intervention. Other entities like Research Laboratories also played their part, especially in the context of clinical research and studies.

Regional Insights

Geographically, North America, in 2024, dominated the market in terms of revenue, backed by a high prevalence of diabetes, advanced healthcare infrastructure, and patient awareness. However, the Asia-Pacific region is expected to display the highest CAGR from 2025 to 2033. Factors such as burgeoning diabetic populations in countries like India and China, coupled with increasing healthcare expenditure and emerging diagnostic facilities, will fuel this growth. Europe, with its mature healthcare systems, will continue to be a significant contributor, while Latin America and Africa will present potential growth opportunities, albeit with challenges related to healthcare access and affordability.

Competitive Trends

The competitive landscape of the HbA1c Laboratory Testing market has always been dynamic. In 2024, key players like Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, ARKRAY, Inc., EKF Diagnostics Holdings plc, Meril Life Science Pvt. Ltd. dominated, leveraging their advanced HPLC and Immunoassay solutions. Their strategies focused on R&D, geographical expansion, and forging partnerships with diagnostic and research labs. As we forecast from 2025 to 2033, it's anticipated that these giants will delve deeper into AI integration and automation, broadening their footprints in emerging markets, and addressing the need for rapid, scalable, and accurate HbA1c testing solutions.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of HbA1c Laboratory Testing market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the HbA1c Laboratory Testing market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
  • Technology
    • Ion Exchange High Performance Liquid Chromatography (HPLC)
    • Immunoassay
    • Boronate Affinity Chromatography
    • Direct Enzymatic Assay
    • Others
  • End-user
    • Diagnostic Laboratories
    • Hospital-based Laboratories
    • Others (Research Laboratories, etc.)
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of HbA1c Laboratory Testing market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the HbA1c Laboratory Testing market?
  • Which is the largest regional market for HbA1c Laboratory Testing market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving HbA1c Laboratory Testing market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the HbA1c Laboratory Testing market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global HbA1c Laboratory Testing Market
  • 2.2. Global HbA1c Laboratory Testing Market, By Technology, 2024 (US$ Million)
  • 2.3. Global HbA1c Laboratory Testing Market, By End-user, 2024 (US$ Million)
  • 2.4. Global HbA1c Laboratory Testing Market, By Geography, 2024 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2024

3. HbA1c Laboratory Testing Market: Competitive Analysis

  • 3.1. Market Positioning of Key HbA1c Laboratory Testing Market Vendors
  • 3.2. Strategies Adopted by HbA1c Laboratory Testing Market Vendors
  • 3.3. Key Industry Strategies

4. HbA1c Laboratory Testing Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global HbA1c Laboratory Testing Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Ion Exchange High Performance Liquid Chromatography (HPLC)
    • 5.3.2. Immunoassay
    • 5.3.3. Boronate Affinity Chromatography
    • 5.3.4. Direct Enzymatic Assay
    • 5.3.5. Others

6. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Diagnostic Laboratories
    • 6.3.2. Hospital-based Laboratories
    • 6.3.3. Others (Research Laboratories, etc.)

7. North America HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 7.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 7.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 7.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 7.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 7.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

8. UK and European Union HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 8.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 8.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.4.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.5.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 8.4.1.6.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

9. Asia Pacific HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 9.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 9.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.4.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.5.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 9.4.1.6.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

10. Latin America HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 10.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 10.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 10.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 10.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 10.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

11. Middle East and Africa HbA1c Laboratory Testing Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
  • 11.3. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
  • 11.4.HbA1c Laboratory Testing Market: By Region, 2023-2033, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 11.4.1.1.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 11.4.1.2.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. HbA1c Laboratory Testing Market: By Technology, 2023-2033, USD (Million)
        • 11.4.1.3.2. HbA1c Laboratory Testing Market: By End-user, 2023-2033, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Bio-Rad Laboratories, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. F. Hoffmann-La Roche Ltd.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Danaher Corporation
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Siemens Healthcare GmbH
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Thermo Fisher Scientific, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Ortho Clinical Diagnostics
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. ARKRAY, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. EKF Diagnostics Holdings plc
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Meril Life Science Pvt. Ltd.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Others
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives